These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

294 related items for PubMed ID: 28771917

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Recognition of PF4-VWF complexes by heparin-induced thrombocytopenia antibodies contributes to thrombus propagation.
    Johnston I, Sarkar A, Hayes V, Koma GT, Arepally GM, Chen J, Chung DW, López JA, Cines DB, Rauova L, Poncz M.
    Blood; 2020 Apr 09; 135(15):1270-1280. PubMed ID: 32077913
    [Abstract] [Full Text] [Related]

  • 23. Further characterization of antibody and antigen in heparin-induced thrombocytopenia.
    Newman PM, Chong BH.
    Br J Haematol; 1999 Nov 09; 107(2):303-9. PubMed ID: 10583216
    [Abstract] [Full Text] [Related]

  • 24. [Anti-heparin/platelet factor 4 antibodies and heparin-induced thrombocytopenia--review].
    Lei Q, Chen L.
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2008 Apr 09; 16(2):457-60. PubMed ID: 18426686
    [Abstract] [Full Text] [Related]

  • 25. Distinct specificity and single-molecule kinetics characterize the interaction of pathogenic and non-pathogenic antibodies against platelet factor 4-heparin complexes with platelet factor 4.
    Litvinov RI, Yarovoi SV, Rauova L, Barsegov V, Sachais BS, Rux AH, Hinds JL, Arepally GM, Cines DB, Weisel JW.
    J Biol Chem; 2013 Nov 15; 288(46):33060-70. PubMed ID: 24097975
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Distinguishing between anti-platelet factor 4/heparin antibodies that can and cannot cause heparin-induced thrombocytopenia.
    Nazi I, Arnold DM, Warkentin TE, Smith JW, Staibano P, Kelton JG.
    J Thromb Haemost; 2015 Oct 15; 13(10):1900-7. PubMed ID: 26291604
    [Abstract] [Full Text] [Related]

  • 28. Platelet binding of IgG from patients with heparin-induced thrombocytopenia.
    Horne MK, Alkins BR.
    J Lab Clin Med; 1996 May 15; 127(5):435-42. PubMed ID: 8621980
    [Abstract] [Full Text] [Related]

  • 29. Cellular immune responses to platelet factor 4 and heparin complexes in patients with heparin-induced thrombocytopenia.
    Nazy I, Clare R, Staibano P, Warkentin TE, Larché M, Moore JC, Smith JW, Whitlock RP, Kelton JG, Arnold DM.
    J Thromb Haemost; 2018 Jul 15; 16(7):1402-1412. PubMed ID: 29723924
    [Abstract] [Full Text] [Related]

  • 30. Platelet transactivation by monocytes promotes thrombosis in heparin-induced thrombocytopenia.
    Tutwiler V, Madeeva D, Ahn HS, Andrianova I, Hayes V, Zheng XL, Cines DB, McKenzie SE, Poncz M, Rauova L.
    Blood; 2016 Jan 28; 127(4):464-72. PubMed ID: 26518435
    [Abstract] [Full Text] [Related]

  • 31. Antibodies from patients with heparin-induced thrombocytopenia/thrombosis are specific for platelet factor 4 complexed with heparin or bound to endothelial cells.
    Visentin GP, Ford SE, Scott JP, Aster RH.
    J Clin Invest; 1994 Jan 28; 93(1):81-8. PubMed ID: 8282825
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Early-onset and persisting thrombocytopenia in post-cardiac surgery patients is rarely due to heparin-induced thrombocytopenia, even when antibody tests are positive.
    Selleng S, Malowsky B, Strobel U, Wessel A, Ittermann T, Wollert HG, Warkentin TE, Greinacher A.
    J Thromb Haemost; 2010 Jan 28; 8(1):30-6. PubMed ID: 19793190
    [Abstract] [Full Text] [Related]

  • 34. Pathogenicity of human anti-platelet factor 4 (PF4)/heparin in vivo: generation of mouse anti-PF4/heparin and induction of thrombocytopenia by heparin.
    Blank M, Cines DB, Arepally G, Eldor A, Afek A, Shoenfeld Y.
    Clin Exp Immunol; 1997 May 28; 108(2):333-9. PubMed ID: 9158107
    [Abstract] [Full Text] [Related]

  • 35. Heparin-induced thrombocytopenia: an autoimmune disorder regulated through dynamic autoantigen assembly/disassembly.
    Cines DB, Rauova L, Arepally G, Reilly MP, McKenzie SE, Sachais BS, Poncz M.
    J Clin Apher; 2007 Feb 28; 22(1):31-6. PubMed ID: 17285619
    [Abstract] [Full Text] [Related]

  • 36. Activated platelets kill Staphylococcus aureus, but not Streptococcus pneumoniae-The role of FcγRIIa and platelet factor 4/heparinantibodies.
    Wolff M, Handtke S, Palankar R, Wesche J, Kohler TP, Kohler C, Gruel Y, Hammerschmidt S, Greinacher A.
    J Thromb Haemost; 2020 Jun 28; 18(6):1459-1468. PubMed ID: 32237268
    [Abstract] [Full Text] [Related]

  • 37. Defining an antigenic epitope on platelet factor 4 associated with heparin-induced thrombocytopenia.
    Ziporen L, Li ZQ, Park KS, Sabnekar P, Liu WY, Arepally G, Shoenfeld Y, Kieber-Emmons T, Cines DB, Poncz M.
    Blood; 1998 Nov 01; 92(9):3250-9. PubMed ID: 9787161
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Pathogenicity of IgA and/or IgM antibodies to heparin-PF4 complexes in patients with heparin-induced thrombocytopenia.
    Amiral J, Wolf M, Fischer A, Boyer-Neumann C, Vissac A, Meyer D.
    Br J Haematol; 1996 Mar 01; 92(4):954-9. PubMed ID: 8616093
    [Abstract] [Full Text] [Related]

  • 40. Evaluation of a new automated panel of assays for the detection of anti-PF4/heparin antibodies in patients suspected of having heparin-induced thrombocytopenia.
    Legnani C, Cini M, Pili C, Boggian O, Frascaro M, Palareti G.
    Thromb Haemost; 2010 Aug 01; 104(2):402-9. PubMed ID: 20539902
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 15.